Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The KPROCS Study: A Real-World and Research Resource to Investigate Multilevel Determinants of Ovarian Cancer Treatment and Survival.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: May 25, 2026
Reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer.
Journal: Gynecologic oncology
Published: January 31, 2025
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 03, 2024
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.
Journal: Nature medicine
Published: September 23, 2024
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
Journal: The New England journal of medicine
Published: March 27, 2023
Role of neighborhood context in ovarian cancer survival disparities: current research and future directions.
Journal: American journal of obstetrics and gynecology
Published: December 06, 2022
Sociodemographic disparities in targeted therapy in ovarian cancer in a national sample.
Journal: Frontiers in oncology
Published: November 21, 2022
A New High Affinity Hemoglobin Variant: Hb San Francisco-KP (HBB: c.104T>C).
Journal: Hemoglobin
Published: June 25, 2021
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients.
Journal: Journal of thrombosis and thrombolysis
Published: January 10, 2021
Association of anticoagulation use with SARS-CoV2 detection.
Journal: Thrombosis research
Published: August 27, 2020
Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio State University Medical Center.
Journal: Pancreas
Published: November 21, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026